IOVA
Iovance Biotherapeutics Inc
10.60$
+4.4%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | +399.6% | +13,699.0% | +60.6% | |
| – | +1,032.4% | -2.1% | -2.7% | +0.4% | +749.7% | +7.3% | +60.5% | +51.2% | -49.1% | +1,052.9% | -94.1% | |
| – | – | – | – | – | – | – | – | – | – | – | +539.3% | |
| – | +471.9% | +81.2% | +155.4% | +39.4% | +66.3% | +21.5% | +28.4% | +13.8% | +16.7% | -17.9% | +6.4% | |
| – | +32.7% | +106.6% | -17.0% | +33.7% | +43.7% | +47.4% | +39.0% | +24.4% | -73.4% | +87.0% | +194.1% | |
| – | +929.9% | +92.5% | +73.2% | +38.1% | +61.3% | +26.6% | +30.8% | +16.4% | +13.1% | -3.5% | +51.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3,433.6% | -100.0% | – | – | – | – | -80.9% | +561.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -324.1% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.